ERIC C HOLLAND, MD
Medical Practice at York Ave, New York, NY

License number
New York 220341
Category
Medical Practice
Type
Neurological Surgery
Address
Address
1275 York Ave, New York, NY 10021
Phone
(646) 227-3813

Personal information

See more information about ERIC C HOLLAND at radaris.com
Name
Address
Phone
Eric Holland
485 Bronx River Rd #3R, Yonkers, NY 10704
Eric Holland, age 50
485 Bronx River Rd APT C31, Yonkers, NY 10704
Eric Holland
345 E 68Th St APT 5F, New York, NY 10065
Eric Holland, age 55
762 Saint Marks Ave APT 2D, Brooklyn, NY 11216
Eric Holland, age 39
7246 Route 16, Franklinville, NY 14737

Organization information

See more information about ERIC C HOLLAND at bizstanding.com

Eric C Holland MD

1275 York Ave #71, New York, NY 10065

Categories:
Physicians & Surgeons
Phone:
(212) 639-3005 (Phone)

Professional information

Eric Holland Photo 1

Air Personality At Wfuv &Amp; Ny1

Position:
Air Personality at WFUV, Editor/Chief Content Provider at Hollandude.com
Location:
Greater New York City Area
Industry:
Broadcast Media
Work:
WFUV since Jun 2008 - Air Personality Hollandude.com since Sep 2007 - Editor/Chief Content Provider NY1-TV 2012 - 2013 - Music Reporter (Sound Advice) Henna Communication Oct 2006 - Aug 2007 - Air Personality WBOS Jan 2002 - Aug 2004 - Air Personality Emerson College May 2001 - Aug 2004 - Broadcasting Teacher Soundcheck Magazine Mar 1999 - Aug 2004 - Staff Writer WZLX 1999 - 2001 - Evening Personality KKLV Feb 1995 - Sep 1998 - Air Personality/Program Director WKGB Sep 1991 - Aug 1994 - Air Personality/Production Director
Education:
Emerson College 2002 - 2004
MA, Media Arts
Ithaca College 1987 - 1991
BS, Television-Radio/Business
Skills:
Radio, Broadcast, Blogging, Editing, Music, Interviewing, Interviews, Voice Over, Copywriting
Interests:
music, new media, radio, Japanese, travel, scrabble,
Languages:
Japanese but was never fluent and much forgotten


Eric Holland Photo 2

Dr. Eric Holland, New York NY - MD (Doctor of Medicine)

Specialties:
Neurosurgery
Address:
MSKCC SURGERY GROUP
1275 York Ave, New York 10065
(800) 525-2225 (Phone)
MSKCC
1275 York Ave, New York 10065
(866) 425-8999 (Phone)
Certifications:
Neurosurgery, 2012
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
MSKCC SURGERY GROUP
1275 York Ave, New York 10065
MSKCC
1275 York Ave, New York 10065
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
Philosophy:
I am a neurosurgeon who specializes in the treatment of gliomas, the most common malignant brain tumor in adults, and metastatic brain tumors. I came to MSKCC in 2001 from MD Anderson Cancer Center, and I am now an Attending in the Departments of Neurology and Neurosurgery, a Member in the Cancer Biology and Genetics Program at the Sloan-Kettering Institute. I am also Director of the Brain Tumor Center here at MSKCC. The Brain Tumor Center is a virtual interdepartmental center that spans Memorial Hospital and Sloan-Kettering Institute to support research in brain tumors and promote its translation into clinical trials. In the laboratory, my work focuses primarily on understanding the molecular mechanisms that underlie the development of central nervous system tumors and on developing models of these cancers in mice. While working as a postdoctoral fellow at the National Institutes of Health in the laboratory of Harold Varmus, I helped develop a technique for somatic cell gene transfer, which has been important for creating mouse models of glioma. My colleagues and I have developed mouse models of eight subtypes of gliomas, including the first truly lifelike model of a glioblastoma -- the most lethal brain tumor in humans. These animal models are essential to making the transition from a scientific concept to understanding the behavior of a human tumor. The mouse modeling experiments we have conducted imply a relationship between the signal transduction abnormalities found in human gliomas and the formation and histologic character of these tumors. My laboratory is supported by grants from the National Institutes of Health and from private foundations. Most recently, I have served on the NIH's Brain Tumor Process Review Group. Currently, I am a member of the Mouse Models of Human Cancer Consortium and the principal investigator on a research project for MSKCC's Specialized Program of Research Excellence (SPORE) grant in brain cancer. Over the years, I have received several awards, including the Searle Scholars Award, the American Brain Tumor Association Research Award, the Peter Steck Memorial Award, the Bressler Scholars Award, and the Seroussi Award. In addition to serving as an ad hoc reviewer for many scientific journals, I am a member of the editorial boards of Virology, Molecular Cancer Research, the Journal of Molecular Medicine, and Neoplasia.
Education:
Medical School
Stanford University School Of Medicine
Graduated: 1990


Eric Holland Photo 3

General Manager At Skechers

Position:
General manager at Skechers
Location:
Greater New York City Area
Industry:
Retail
Work:
Skechers - General manager


Eric C Holland Photo 4

Eric C Holland, New York NY

Specialties:
Neurosurgeon
Address:
1275 York Ave, New York, NY 10065
633 3Rd Ave, New York, NY 10017
Education:
Doctor of Medicine
Board certifications:
American Board of Neurological Surgery Certification in Neurological Surgery


Eric Holland Photo 5

Eric Holland

Location:
Greater New York City Area
Industry:
Professional Training & Coaching


Eric Holland Photo 6

Eric Holland

Specialties:
Buyer's Agent, Listing Agent
Work:
AC Lawrence
936 Broadway, New York 10010


Eric Holland Photo 7

Eric Holland, New York NY - Agent

Work:
AC Lawrence
New York
(914) 584-7549
Property type:
Residential Rental


Eric Holland Photo 8

Transgenic Luciferase Mouse

US Patent:
7041869, May 9, 2006
Filed:
Oct 3, 2003
Appl. No.:
10/679231
Inventors:
Eric Charles Holland - New York NY, US
Assignee:
Sloan-Kettering Institute for Cancer Research - New York NY
International Classification:
A01K 67/00
US Classification:
800 8, 800 3, 800 21
Abstract:
The present invention provides a transgenic animal expressing the reporter gene, luciferase, driven by a promoter (e. g. the E2F1 promoter) that acts as a sensor of cell cycle. The luciferase substrate, luciferin, emits light when metabolized, and the light is transmitted through mammalian tissues. Therefore, the transgenic animal model of the present invention allows for monitoring of areas of major cell cycle activity, a characteristic of cancer cells, under adequate visualization conditions. These transgenic animals are useful as in vivo models for testing preventative measures for cancer as well as for testing novel therapeutic modalities.